Ocean Biomedical Terminates Material Definitive Agreement
Ticker: OCEA · Form: 8-K · Filed: Jun 13, 2025 · CIK: 1869974
Sentiment: neutral
Topics: material-agreement-termination
TL;DR
Ocean Biomedical just terminated a big deal. What's next?
AI Summary
Ocean Biomedical, Inc. announced on June 12, 2025, the termination of a material definitive agreement. The company, formerly known as Aesther Healthcare Acquisition Corp., is incorporated in Delaware and its principal executive offices are located in Providence, RI.
Why It Matters
The termination of a material definitive agreement can significantly impact a company's strategic direction and financial obligations.
Risk Assessment
Risk Level: medium — Termination of a material definitive agreement can indicate underlying issues or a change in strategic direction, introducing uncertainty.
Key Players & Entities
- Ocean Biomedical, Inc. (company) — Registrant
- Aesther Healthcare Acquisition Corp. (company) — Former company name
- June 12, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Providence, RI (location) — Address of principal executive offices
FAQ
What was the specific material definitive agreement that was terminated?
The filing states that a material definitive agreement was terminated, but does not specify which agreement.
When did the termination of the material definitive agreement become effective?
The earliest event reported is June 12, 2025, which is the date of the report and the date as of which the change occurred.
What are the principal executive offices of Ocean Biomedical, Inc.?
The principal executive offices are located at 55 Claverick St., Room 325, Providence, RI 02903.
What was Ocean Biomedical, Inc. formerly known as?
Ocean Biomedical, Inc. was formerly known as Aesther Healthcare Acquisition Corp. until a name change on February 14, 2023.
What is the SIC code for Ocean Biomedical, Inc.?
The Standard Industrial Classification (SIC) code for Ocean Biomedical, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 13, 2025 regarding Ocean Biomedical, Inc. (OCEA).